These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14163111)

  • 1. EVALUATION OF A CORONARY VASODILATOR, DIPYRIDAMOLE (PERSANTIN).
    HARDY JD; KURRUS FD; CHAVEZ CM; NEELY WA; ERASLAN S; TURNER MD; FABIAN LW; LABECKI TD
    JAMA; 1964 Jun; 188():1141. PubMed ID: 14163111
    [No Abstract]   [Full Text] [Related]  

  • 2. [CLINICO-EXPERIMENTAL STUDIES ON THE POSITIVE INOTROPIC EFFECT OF PERSANTIN].
    KOENIG E; TREPEL F
    Med Klin; 1964 Apr; 59():624-33. PubMed ID: 14199978
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies with a new coronary vasodilator drug: persantin.
    KINSELLA D; TROUP W; McGREGOR M
    Am Heart J; 1962 Feb; 63():146-51. PubMed ID: 14456202
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the coronary vasodilator effect of 'persantin'.
    PEEL AA; BLUM K; LANCASTER WM; DALL JL; CHALMERS GL
    Scott Med J; 1961 Sep; 6():403-10. PubMed ID: 13733892
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of Persantin (RA8), a new coronary vasodilator, on coronary blood flow and cardiac dynamics in the dog.
    WEST JW; BELLET S; MANZOLI UC; MUELLER OF
    Circ Res; 1962 Jan; 10():35-44. PubMed ID: 14006308
    [No Abstract]   [Full Text] [Related]  

  • 6. [The coronary vasodilator effect of Persantin].
    PEEL AA; BLUM K; LANCASTER WM; DALL JL; CHALMERS GL
    Verh Dtsch Ges Kreislaufforsch; 1961; 27():314-20. PubMed ID: 14484876
    [No Abstract]   [Full Text] [Related]  

  • 7. AUGMENTATION OF INTERCORONARY ANASTOMOSIS BY LONG-TERM ADMINISTRATION OF A VASODILATOR DRUG, DIPYRIDAMOLE (PERSANTIN).
    FAM WM; RAGHEB S; HOESCHEN RJ
    Can Med Assoc J; 1964 Apr; 90(16):970-3. PubMed ID: 14139998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PHARMACOLOGY OF CORONARY VASODILATOR AGENTS].
    HASHIMOTO T
    Sogo Rinsho; 1964 Mar; 13():445-51. PubMed ID: 14140831
    [No Abstract]   [Full Text] [Related]  

  • 9. [The hypoxia test in evaluation of coronary-active drugs, especially of persantin in man].
    NEUHAUS G; LERCHE D; SCHUCK P
    Med Klin; 1961 Apr; 56():695-9. PubMed ID: 13728518
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of coronary insufficiency with Persantin].
    RIEGLER E
    Wien Z Inn Med; 1961 Mar; 42():140-2. PubMed ID: 13741533
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of persantin on coronary flow and cardiac dynamics.
    ELLIOT EC
    Can Med Assoc J; 1961 Aug; 85(9):469-76. PubMed ID: 13726418
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical and experimental studies on persantin in coronary diseases].
    GREIF S
    Wien Med Wochenschr; 1960 Jun; 110():463-6. PubMed ID: 13851721
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of coronary insufficiency with 2, 6-bis(diethylamino)-4, 8-dipiperidino-pyrimido(5, 4-d)pyrimidine (persantin)].
    LANG O
    Wien Med Wochenschr; 1959 Dec; 109():1006-7. PubMed ID: 14413872
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical results with a new coronary dilatator agent: persantin].
    MARTINEZ RAMON E; ALCALA LLORENTE E
    Med Esp; 1961 Jun; 45():470-87. PubMed ID: 13767501
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trials with persantin in the therapy of coronary and myocardial insufficiency].
    ROESELER E
    Med Welt; 1960 Nov; 48():2562-4. PubMed ID: 13742702
    [No Abstract]   [Full Text] [Related]  

  • 16. [On heart therapy with Persantin].
    WOLF H
    Wien Med Wochenschr; 1961 May; 111():357-61. PubMed ID: 13786276
    [No Abstract]   [Full Text] [Related]  

  • 17. [Persantin in arteriosclerotic cardiac disease. Study of 30 patients].
    RODRIGUEZ ALVAREZ J
    Med Esp; 1961 Mar; 45():235-41. PubMed ID: 13742567
    [No Abstract]   [Full Text] [Related]  

  • 18. [5,4-d] pyrimidine (Persantin)].
    BETZ E; BRAASCH D; HENSEL H
    Verh Dtsch Ges Kreislaufforsch; 1961; 27():321-6. PubMed ID: 13868680
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of persantin on intercoronary collateral circulation and survival during gradual experimental coronary occlusion. A preliminary report.
    VINEBERG AM; CHARI RS; PIFARRE R; MERCIER C
    Can Med Assoc J; 1962 Aug; 87(7):336-45. PubMed ID: 13926101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental research on modifications of the coronary arteriographic picture induced by 2,6-bis(diethanolamino) 4,8,-dipiperidino-pyrimido(5,4-d) pyrimidine (Persantin)].
    AGATI G; NATTERO G; GULLINO D; FERRARA L; VIDILI F
    Minerva Cardioangiol; 1961 Nov; 9():701-5. PubMed ID: 13859565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.